Evidence mapPaperPMID 40824567Full record

ReviewClinical reviews in allergy & immunology2025

Islet Tissue Macrophages in Immunity Homeostasis and Type 1 Diabetes.

Yan Wang, Zhaoran Wang, Wenya Diao, Tong Shi, Jiahe Xu, Tiantian Deng, Chaoying Wen, Jienan Gu, Tingting Deng, Sixuan Wang and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yan WangChina-Japan Friendship Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhaoran WangInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Wenya DiaoChina-Japan Friendship Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, China.
Tong ShiInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Jiahe XuInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Tiantian DengChina-Japan Friendship Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, China.
Chaoying WenInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Jienan GuChina-Japan Friendship Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, China.
Tingting DengInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Sixuan WangDepartment of Integrative Diabetes Medicine, National Center for Integrative Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China. wangsixuan@zryhyy.com.cn.
Cheng XiaoInstitute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. xc2002812@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Islet macrophages are considered to be irreplaceable in maintaining the immune microenvironment homeostasis. The M1/M2 imbalance can trigger the initiation of islet autoimmunity and persists throughout the entire process of type 1 diabetes. The identification of macrophage transcriptional clusters and phenotypes by single-cell sequencing has facilitated in-depth studies on the role of macrophages in the pathogenesis of type 1 diabetes. Macrophages exert extensive endocrine and paracrine effects on the islets by secreting various bioactive chemicals, especially exosomes, which facilitate cell-cell communication. Resident islet macrophages directly influence the biological properties of islet tissue. Meanwhile, the interaction between macrophages and islet cells is bidirectional. Cell-cell interactions also closely govern the polarization and activity of macrophages. An imbalance in the transition from M2 to M1 macrophages may lead to inflammation and islet dysfunction. Here, we have discussed the latest research progress on macrophages in the islet immune microenvironment homeostasis, the mechanisms of interactions between macrophages and islet cells in type 1 diabetes, and analyzed the possible clinical consequences. Furthermore, we highlighted emerging technologies for non-invasive detection of macrophages and summarized how therapeutic targeting of macrophages may be beneficial for patients with type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1HomeostasisIslets of LangerhansMacrophagesAnimalsAutoimmunityCell CommunicationCellular MicroenvironmentHumansMacrophage ActivationCell communicationDiabetesExosomesImmunity homeostasisMacrophageβ cell

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.